Lanreotide API Manufacturers & Suppliers
Find, compare & contact
Filters
Custom request?
Type
Production region
Qualifications
Country of origin
Distributor
Produced in:
Established in: 2011
MOQ: -
Employees: 25
Technical expertise ensuring optimal selection and development of APIs and intermediates
Globally connected with multiple GMP-compliant manufacturing facilities
Regulatory excellence with a dedicated team with global reach
+ 0
All certificates
Produced in:
Established in: 1993
MOQ: -
Employees: 373
Specialization in Peptide and Small Molecule Drug Development
GMP-Compliant Manufacturing Focused on Sterile and Non-Sterile Production
New Manufacturing 59,500 m² Facility for Growing Demand
+ 0
All certificates
Producer
+ 0
All certificates
How does it work?
You can register for free as long as you are registering on behalf of a legal company related to the pharmaceutical industry
Search in the search bar the product that you’re looking for. We’ll show you an overview of all available suppliers. Use the filters to select the relevant suppliers only
Have you found interesting suppliers? Then it’s time to contact them. Use the send inquiry button and send them a message. You can send for each product, 3 inquiries per week
Suppliers get notified by Pharmaoffer that they’ve received a new inquiry. They will come back to you with their questions, certificates, and offer in the chat on Pharmaoffer. We will send you an email in case of any news
Does the supplier meet your quality and commercial requirements? Then you can place the order. Just follow the steps of our order module
Looking for Lanreotide API 108736-35-2?
- Description:
- Here you will find a list of producers, manufacturers and distributors of Lanreotide. You can filter on certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.
- API | Excipient name:
- Lanreotide
- Synonyms:
- Lanreotide acetate , Lanreotide , Somatuline Depot
- Cas Number:
- 108736-35-2
- DrugBank number:
- DB06791
- Unique Ingredient Identifier:
- 0G3DE8943Y
About Lanreotide
Here is a short description about Lanreotide. Lanreotide is a drug employed in the management of acromegaly (a hormonal condition caused by excess growth hormone) in addition to symptoms caused by neuroendocrine tumors, especially carcinoid syndrome. This drug is a long-acting analog of the drug somatostatin, a growth hormone inhibitor. Lanreotide is manufactured by the company, Ipsen Pharmaceuticals as lanreotide acetate, and marketed as Somatuline. It is approved in several countries worldwide, including the United Kingdom, Australia, and Canada. Lanreotide was first approved for use in the United States by the FDA on August 30, 2007.
You can find more info about this product by clicking on the DB ID above.
Lanreotide is a type of Somatostatin Analogs
Somatostatin analogs are a subcategory of pharmaceutical active pharmaceutical ingredients (APIs) used in the treatment of various medical conditions. These analogs are synthetic versions of somatostatin, a hormone naturally produced in the body.
Somatostatin analogs are primarily used in the management of conditions such as acromegaly, a hormonal disorder characterized by excessive growth hormone production, and neuroendocrine tumors (NETs), which are tumors that arise from the neuroendocrine cells.
These analogs function by mimicking the actions of somatostatin in the body. Somatostatin normally inhibits the release of several hormones, including growth hormone, insulin, glucagon, and gastrin. By imitating somatostatin's inhibitory effects, somatostatin analogs help regulate the production and release of these hormones.
One commonly used somatostatin analog is octreotide, which is available in various formulations, including injectable and long-acting depot formulations. Octreotide is administered to control symptoms associated with acromegaly and NETs, such as excessive growth, hormone overproduction, and tumor growth.
Other somatostatin analogs like lanreotide and pasireotide have also been developed and are used for similar indications. These analogs offer an extended duration of action and can be administered via subcutaneous injections.
In summary, somatostatin analogs are a crucial category of APIs utilized in the management of conditions like acromegaly and neuroendocrine tumors. They act by replicating the inhibitory effects of somatostatin and are available in various formulations to meet different patient needs. Octreotide, lanreotide, and pasireotide are examples of commonly used somatostatin analogs in clinical practice.
Lanreotide (Somatostatin Analogs), classified under Hormonal Agents
Hormonal agents are a prominent category of pharmaceutical active pharmaceutical ingredients (APIs) widely used in the medical field. These substances play a crucial role in regulating and modulating hormonal functions within the body. Hormonal agents are designed to mimic or manipulate the effects of naturally occurring hormones, allowing healthcare professionals to treat various endocrine disorders and hormonal imbalances.
Hormonal agents are commonly employed in the treatment of conditions such as hypothyroidism, hyperthyroidism, diabetes, and hormonal cancers. These APIs work by interacting with specific hormone receptors, either by stimulating or inhibiting their activity, to restore the balance of hormones in the body. They can be administered orally, intravenously, or through other routes depending on the specific medication and patient needs.
Pharmaceutical companies employ rigorous manufacturing processes and quality control measures to ensure the purity, potency, and safety of hormonal agent APIs. These APIs are synthesized using chemical or biotechnological methods, often starting from natural hormone sources or through recombinant DNA technology. Stringent regulatory guidelines are in place to guarantee the efficacy and safety of hormonal agent APIs, ensuring that patients receive high-quality medications.
As the demand for hormone-related therapies continues to grow, ongoing research and development efforts focus on enhancing the effectiveness and reducing the side effects of hormonal agent APIs. This includes the exploration of novel delivery systems, advanced formulations, and targeted drug delivery methods. By continuously advancing our understanding and capabilities in hormonal agents, the medical community can improve patient outcomes and quality of life for individuals with hormonal disorders.
Lanreotide manufacturers | traders | suppliers
We have 3 companies offering Lanreotide produced in 0 different countries.
Get in contact with the supplier of your choice:
- Global Pharma Tek from India, product country of origin India
- Suzhou Tianma Pharma Group Tianji Bio-Pharmaceutical Co., Ltd from China, product country of origin China
- ALP PHARM from China, product country of origin China
Let the supplier know whether you are looking for a product with a specific monograph such as EP (Ph. Eur.), USP, JP, BP or another quality. Or, whether you are looking for hydrochloride (HCl), anhydricum, base, micronisatum or a specific purity.
You can use the filters to find high-quality suppliers. For example, you can select GMP, FDA or ISO certified suppliers. Visit our FAQ page or use the chat box in the corner to get more information about Pharmaoffer.
